Target Product Profiles: Physician Insights on Key Attributes - Post-Myocardial Infarction, A therapy that, combined with aspirin, causes less major bleeding than the combination of clopidogrel and aspirin for the treatment of postmyocardial infarction.

Table of Contents

• Introduction
  • Using Target Product Profi les in Your Market Strategy
  • Report Contents
  • Target Product Profi le Methodology
• Etiology and Pathophysiology
  • Overview
  • Pathophysiology
    • Response-to-Injury Hypothesis
    • Atherosclerotic Lesions
    • Role of Lipoproteins
    • Role of Platelets
    • Role of Coagulation
    • Electrophysiological Perspectives
  • Etiology
    • Left-Ventricular Remodeling and Dysfunction
    • Prognostic Signifi cance of Left-Ventricular Ejection Fraction
    • Infl uential Factors in Ventricular Remodeling
    • Arrhythmias and Sudden Cardiac Death
    • Traditional Risk Factors
• Infl ammatory Markers as Measures of Risk
  • Target Product Profi le Discussion-Post-Myocardial Infarction
  • Target Product Profi le Summary for Post-Myocardial Infarction-2011
  • Assessing Drug Development Opportunities
  • Physician Survey Results
    • Effi cacy
    • Safety and Tolerability
    • Delivery
    • Estimated Patient Share
  • Pricing Potential
  • Forecasted 2016 Pricing Environment
  • Competitors to Watch
  • Emerging Product Profi les